International Journal of Endocrinology and Metabolism

Published by: Kowsar

Hypogonadism and Metabolic Syndrome in Nigerian Male Patients With Both Type 2 Diabetes and Hypertension

Oluyemi Akinloye 1 , * , Bolutife Blessing Popoola 1 , Mary Bolanle Ajadi 1 , Joseph Gregory Uchechukwu 1 and Dolapo Pius Oparinde 1
Authors Information
1 Department of Chemical Pathology, Faculty of Basic Medical Sciences, College of Health Sciences, Ladoke University of Technology, Osogbo, Osun State, Nigeria
Article information
  • International Journal of Endocrinology and Metabolism: January 01, 2014, 12 (1); e10749
  • Published Online: January 1, 2014
  • Article Type: Research Article
  • Received: March 2, 2013
  • Revised: May 10, 2013
  • Accepted: May 27, 2013
  • DOI: 10.5812/ijem.10749

To Cite: Akinloye O, Blessing Popoola B, Bolanle Ajadi M, Gregory Uchechukwu J, Pius Oparinde D. et al. Hypogonadism and Metabolic Syndrome in Nigerian Male Patients With Both Type 2 Diabetes and Hypertension, Int J Endocrinol Metab. 2014 ;12(1):e10749. doi: 10.5812/ijem.10749.

Abstract
Copyright © 2014, Research Institute For Endocrine Sciences and Iran Endocrine Society. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Meigs JB. Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors. Am J Epidemiol. 2000; 152(10): 908-911[DOI]
  • 2. Enzyme immunoassay technique. In WHO Special Program Research in Human Reproduction. Program for Provision of Matched Assay Reagents for Immunoassay of Hormones, Immunometrics (UK), London. 1999;
  • 3. Reaven GM. Role of Insulin Resistance in Human Disease. Diabetes. 1988; 37(12): 1595-1607[DOI]
  • 4. Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab. 2007; 92(2): 396-8[DOI][PubMed]
  • 5. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004; 89(11): 5462-8[DOI][PubMed]
  • 6. Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007; 30(4): 911-7[DOI][PubMed]
  • 7. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003; 24(3): 313-40[DOI][PubMed]
  • 8. Wu GX, Wu ZS, Liu J, Wang W, Zhao D, Hou L, et al. [A study on the incidence of cardiovascular disease on the metabolic syndrome in 11 provinces in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2003; 24(7): 551-3[PubMed]
  • 9. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf). 2005; 63(3): 239-50[DOI][PubMed]
  • 10. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996; 334(15): 952-7[DOI][PubMed]
  • 11. Feldman HA. Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study. J Clin Endocrinol Metabol. 2002; 87(2): 589-598[DOI]
  • 12. Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, et al. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care. 1989; 12(8): 530-6[PubMed]
  • 13. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006; 91(3): 843-50[DOI][PubMed]
  • 14. Tomar R, Dhindsa S, Chaudhuri A, Mohanty P, Garg R, Dandona P. Contrasting testosterone concentrations in type 1 and type 2 diabetes. Diabetes Care. 2006; 29(5): 1120-2[DOI][PubMed]
  • 15. Robert S, Griffith J. Low testosterone levels linked to atherosclerosis. J Cardiovas Pharmacol. 2003; 19: 123-127
  • 16. Dobryeki S, Zukowska Serwatka, Ladny JR. Pathogenic basis of androgen administration in Cardiology. Pol Merkurius Lek. 2003; 14: 268-270
  • 17. Svartberg J. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Europ J Endocrinol. 2004; 150(1): 65-71[DOI]
  • 18. Osuna JA, Gomez-Perez R, Arata-Bellabarba G, Villaroel V. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl. 2006; 52(5): 355-61[DOI][PubMed]
  • 19. Svartberg J, von Muhlen D, Sundsfjord J, Jorde R. Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol. 2004; 19(7): 657-63[PubMed]
  • 20. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension. 1999; 34(4 Pt 2): 920-3[PubMed]
  • 21. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol. 2002; 58(3): 177-80[DOI][PubMed]
  • 22. Farshchi H, Shahnazi A, Azizi F. Effects of testosterone and gonadotropin therapy in men with hypogonadotropic hypogonadism. Int J Endocrinol Metab. 2009; 7(4): 242-247
  • 23. Harande YI. Exploring the literature of diabetes in Nigeria: a bibliometrics study. Afr J Diabetes Med Vol. 2011; 19(2)
  • 24. Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S. Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003; 62(3): 177-85[PubMed]
  • 25. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol. 1969; 22(2): 246-246[DOI]
  • 26. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973; 19(5): 476-82[PubMed]
  • 27. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20(4): 470-5[PubMed]
  • 28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6): 499-502[PubMed]
  • 29. Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab. 2007; 92(9): 3568-72[DOI][PubMed]
  • 30. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006; 60(7): 762-9[DOI][PubMed]
  • 31. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl. 2009; 30(1): 23-32[DOI][PubMed]
  • 32. Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006; 18(2): 190-7[DOI][PubMed]
  • 33. Esposito K, Giugliano F, Martedi E, Feola G, Marfella R, D'Armiento M, et al. High Proportions of Erectile Dysfunction in Men With the Metabolic Syndrome. Diabetes Care. 2005; 28(5): 1201-1203[DOI]
  • 34. Park K, Ku JH, Kim SW, Paick JS. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int. 2005; 95(3): 366-70[DOI][PubMed]
  • 35. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The Metabolic Syndrome as Predictor of Type 2 Diabetes: The San Antonio Heart Study. Diabetes Care. 2003; 26(11): 3153-3159[DOI]
  • 36. Fukui M, Soh J, Tanaka M, Kitagawa Y, Hasegawa G, Yoshikawa T, et al. Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J. 2007; 54(6): 871-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments